Works matching IS 09395555 AND DT 2013 AND VI 92 AND IP 10
Results: 23
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".
- Published in:
- 2013
- By:
- Publication type:
- journal article
Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1319, doi. 10.1007/s00277-013-1868-0
- By:
- Publication type:
- Article
A case of late onset erythropoietic protoporphyria associated with myelodysplastic syndrome treated by the combination of beta carotene and azacitidine.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1379, doi. 10.1007/s00277-013-1862-6
- By:
- Publication type:
- Article
Necrotic and ulcerated cutaneous and mucosal leukemia cutis in AML6.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Optic neuritis preceding progressive outer retinal necrosis in an immunocompromised patient after allogeneic stem cell transplantation.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Disseminated plasmacytomas in multiple myeloma: atypical presentations on multimodality images, emphasized on PET/CT.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP).
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1405, doi. 10.1007/s00277-013-1794-1
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1389, doi. 10.1007/s00277-013-1774-5
- By:
- Publication type:
- Article
Life-threatening bleeding tendency provoked by an acquired isolated factor X deficiency associated with respiratory infection.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1295, doi. 10.1007/s00277-013-1796-z
- By:
- Publication type:
- Article
The role of F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin's lymphoma patients.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1369, doi. 10.1007/s00277-013-1782-5
- By:
- Publication type:
- Article
Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1397, doi. 10.1007/s00277-013-1790-5
- By:
- Publication type:
- Article
Acute vesiculobullous hand dermatitis and anagen effluvium in Ganoderma lucidum-induced aplastic crisis.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Pure red cell aplasia associated with CD20+ myeloma: complete remission with rituximab.
- Published in:
- 2013
- By:
- Publication type:
- Letter
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened 'GO question'.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1309, doi. 10.1007/s00277-013-1780-7
- By:
- Publication type:
- Article
Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1351, doi. 10.1007/s00277-013-1770-9
- By:
- Publication type:
- Article
Novel FGFR3 rearrangement t(4;22)(p16;q11.2) in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma.
- Published in:
- 2013
- By:
- Publication type:
- Letter
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1335, doi. 10.1007/s00277-013-1776-3
- By:
- Publication type:
- Article
Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1359, doi. 10.1007/s00277-013-1775-4
- By:
- Publication type:
- Article
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1325, doi. 10.1007/s00277-013-1772-7
- By:
- Publication type:
- Article
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1345, doi. 10.1007/s00277-013-1769-2
- By:
- Publication type:
- Article